Multivariate receiver-operating characteristic curve analysis: prostate cancer screening as an example.

The evolution of test performance analysis should include the long-term costs and benefits associated with testing. Evolutionary laboratory techniques to achieve this include introduction of a new methodological technique, a multivariate extension to a current analytical technique, receiver-operating characteristic (ROC) curve analysis (MultiROC analysis). This extension to ROC methodology allows the comparison of composite test rules in a format similar to that of ROC curves. Statistical properties, guidelines for use, and a detailed example are described. MultiROC is used in the outcomes analysis of the value of screening for prostate cancer. The effect of age and different test decision thresholds are examined in an extension of a previously published outcomes analysis. The results indicate that the variations in test performances caused by these components are important in assigning a final cost:benefit ratio of screening for prostate cancer.

[1]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[2]  L B Lusted,et al.  Radiographic applications of receiver operating characteristic (ROC) curves. , 1974, Radiology.

[3]  A decision analysis of alternative treatment strategies for clinically localized prostate cancer. Prostate Patient Outcomes Research Team. , 1993 .

[4]  S. Pauker,et al.  The Markov Process in Medical Prognosis , 1983, Medical decision making : an international journal of the Society for Medical Decision Making.

[5]  L. Wilkins.  Jones Criteria (Revised) for Guidance in the Diagnosis of Rheumatic Fever , 1965, Circulation.

[6]  R. Galen,et al.  The Assessment of Laboratory Tests in the Diagnosis of Acute Appendicitis , 1984 .

[7]  S G Pauker,et al.  Screening for prostate cancer. A decision analytic view. , 1994, JAMA.

[8]  J R Beck,et al.  The use of relative operating characteristic (ROC) curves in test performance evaluation. , 1986, Archives of pathology & laboratory medicine.

[9]  J. Swets.  ROC analysis applied to the evaluation of medical imaging techniques. , 1979, Investigative radiology.

[10]  W. Catalona,et al.  Clinical use of prostate specific antigen in patients with prostate cancer. , 1989, The Journal of urology.

[11]  J. Hanley,et al.  A method of comparing the areas under receiver operating characteristic curves derived from the same cases. , 1983, Radiology.

[12]  L. Holmberg,et al.  High 10-year survival rate in patients with early, untreated prostatic cancer. , 1992, JAMA.

[13]  A S Detsky,et al.  How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. , 1992, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[14]  M. Zweig,et al.  Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. , 1993, Clinical chemistry.

[15]  M. Hochberg,et al.  An approach to developing criteria for the clinical diagnosis and classification of osteoarthritis: a status report of the American Rheumatism Association Diagnostic Subcommittee on Osteoarthritis. , 1983, The Journal of rheumatology.

[16]  M. Barry,et al.  A decision analysis of alternative treatment strategies for clinically localized prostate cancer. Prostate Patient Outcomes Research Team. , 1993, JAMA.

[17]  R. Kane,et al.  The relationship of prostate‐specific antigen to digital rectal examination and transrectal ultrasonography: Findings of the American cancer society national prostate cancer detection project , 2010, Cancer.

[18]  B. Efron,et al.  A Leisurely Look at the Bootstrap, the Jackknife, and , 1983 .